These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 10452325)

  • 41. [(131)I labeling and bioactivity evaluation of a novel RGD dimer targeted to integrin αvβ3 receptor].
    Zhang CL; Wang RF; Zhang L; Guo FQ; Li L; Kang L; Yan P; Yang M
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):295-300. PubMed ID: 21503130
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography.
    Demignot S; Pimm MV; Thorpe SR; Baldwin RW
    Cancer Immunol Immunother; 1991; 33(6):359-66. PubMed ID: 1878889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of radiolabeled type IV collagen fragments as potential tumor imaging agents.
    Edwards WB; Anderson CJ; Fields GB; Welch MJ
    Bioconjug Chem; 2001; 12(6):1057-65. PubMed ID: 11716700
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo evaluation and dosimetry of 123I-2-iodo-D-phenylalanine, a new potential tumor-specific tracer for SPECT, in an R1M rhabdomyosarcoma athymic mouse model.
    Kersemans V; Cornelissen B; Bacher K; Kersemans K; Thierens H; Dierckx RA; De Spiegeleer B; Slegers G; Mertens J
    J Nucl Med; 2005 Dec; 46(12):2104-11. PubMed ID: 16330577
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and evaluation of a new tumor cell-binding peptide, FROP-1.
    Zitzmann S; Krämer S; Mier W; Hebling U; Altmann A; Rother A; Berndorff D; Eisenhut M; Haberkorn U
    J Nucl Med; 2007 Jun; 48(6):965-72. PubMed ID: 17504878
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors.
    John CS; Gulden ME; Li J; Bowen WD; McAfee JG; Thakur ML
    Nucl Med Biol; 1998 Apr; 25(3):189-94. PubMed ID: 9620622
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of DOTA-conjugated multivalent cyclic-RGD peptide dendrimers via 1,3-dipolar cycloaddition and their biological evaluation: implications for tumor targeting and tumor imaging purposes.
    Dijkgraaf I; Rijnders AY; Soede A; Dechesne AC; van Esse GW; Brouwer AJ; Corstens FH; Boerman OC; Rijkers DT; Liskamp RM
    Org Biomol Chem; 2007 Mar; 5(6):935-44. PubMed ID: 17340009
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Use of a peptide derived from foot-and-mouth disease virus for the noninvasive imaging of human cancer: generation and evaluation of 4-[18F]fluorobenzoyl A20FMDV2 for in vivo imaging of integrin alphavbeta6 expression with positron emission tomography.
    Hausner SH; DiCara D; Marik J; Marshall JF; Sutcliffe JL
    Cancer Res; 2007 Aug; 67(16):7833-40. PubMed ID: 17699789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alpha v integrin antagonists induce the disassembly of focal contacts in melanoma cells.
    Castel S; Pagan R; García R; Casaroli-Marano RP; Reina M; Mitjans F; Piulats J; Vilaró S
    Eur J Cell Biol; 2000 Jul; 79(7):502-12. PubMed ID: 10961450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 5-[123I/125I]iodo-2'-deoxyuridine in metastatic lung cancer: radiopharmaceutical formulation affects targeting.
    Semnani ES; Wang K; Adelstein SJ; Kassis AI
    J Nucl Med; 2005 May; 46(5):800-6. PubMed ID: 15872354
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Receptor-Mediated Melanoma Targeting with Radiolabeled α-Melanocyte-Stimulating Hormone: Relevance of the Net Charge of the Ligand.
    Bapst JP; Eberle AN
    Front Endocrinol (Lausanne); 2017; 8():93. PubMed ID: 28491052
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Radiolabeled tracers for imaging of tumor angiogenesis and evaluation of anti-angiogenic therapies.
    Haubner R; Wester HJ
    Curr Pharm Des; 2004; 10(13):1439-55. PubMed ID: 15134568
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variation of Specific Activities of 68Ga-Aquibeprin and 68Ga-Avebetrin Enables Selective PET Imaging of Different Expression Levels of Integrins α5β1 and αvβ3.
    Notni J; Steiger K; Hoffmann F; Reich D; Schwaiger M; Kessler H; Wester HJ
    J Nucl Med; 2016 Oct; 57(10):1618-1624. PubMed ID: 27151985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Probing for integrin alpha v beta3 binding of RGD peptides using fluorescence polarization.
    Wang W; Wu Q; Pasuelo M; McMurray JS; Li C
    Bioconjug Chem; 2005; 16(3):729-34. PubMed ID: 15898744
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis, SAR and in vitro evaluation of new cyclic Arg-Gly-Asp pseudopentapeptides containing a s-cis peptide bond as integrin alphavbeta3 and alphavbeta5 ligands.
    Salvati M; Cordero FM; Pisaneschi F; Melani F; Gratteri P; Cini N; Bottoncetti A; Brandi A
    Bioorg Med Chem; 2008 Apr; 16(8):4262-71. PubMed ID: 18343671
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Alpha v integrins as receptors for tumor targeting by circulating ligands.
    Pasqualini R; Koivunen E; Ruoslahti E
    Nat Biotechnol; 1997 Jun; 15(6):542-6. PubMed ID: 9181576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Design, synthesis, and evaluation of radiolabeled integrin alpha v beta 3 receptor antagonists for tumor imaging and radiotherapy.
    Harris TD; Kalogeropoulos S; Nguyen T; Liu S; Bartis J; Ellars C; Edwards S; Onthank D; Silva P; Yalamanchili P; Robinson S; Lazewatsky J; Barrett J; Bozarth J
    Cancer Biother Radiopharm; 2003 Aug; 18(4):627-41. PubMed ID: 14503959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pharmacokinetics and tumor retention of 125I-labeled RGD peptide are improved by PEGylation.
    Chen X; Park R; Shahinian AH; Bading JR; Conti PS
    Nucl Med Biol; 2004 Jan; 31(1):11-9. PubMed ID: 14741566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
    van Hagen PM; Breeman WA; Bernard HF; Schaar M; Mooij CM; Srinivasan A; Schmidt MA; Krenning EP; de Jong M
    Int J Cancer; 2000 Aug; 90(4):186-98. PubMed ID: 10993959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vivo therapy of malignant melanoma by means of antagonists of alphav integrins.
    Mitjans F; Meyer T; Fittschen C; Goodman S; Jonczyk A; Marshall JF; Reyes G; Piulats J
    Int J Cancer; 2000 Sep; 87(5):716-23. PubMed ID: 10925366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.